| Hypoglycaemia in People With Type 2 Diabetes in Primary Care (NCT02666521) | University of Leicester | 2012-07-20 |
| High Potency Statins and the Risk of Diabetes (NCT02518503) | Canadian Network for Observational Drug Effect Studies, CNODES | 2012-07-01 |
| Supporting Practices to Adopt Registry-Based Care (NCT02318108) | Mathematica Policy Research, Inc. | 2012-07-01 |
| Social Determinants of Health in Diabetes Outcomes (NCT01749345) | Medical University of South Carolina | 2012-07-01 |
| Pharmaceutical Care Program for Type 2 Diabetes Mellitus (NCT02435693) | TABREJ MUJAWAR | 2012-07-01 |
| A Single-dose Phase 1 Study of DBPR108 in Healthy Male Subjects (NCT01650324) | National Health Research Institutes, Taiwan | 2012-07-01 |
| Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment (NCT01620489) | Novo Nordisk A/S | 2012-06-14 |
| Evaluate Adherence to Treatment With Glucophage Sachets Versus Tablets in Diabetes Type 2 Patients Previously Treated With Metformin Tablets (NCT01510522) | Merck KGaA, Darmstadt, Germany | 2012-06-01 |
| Evaluation of CONTOUR® USB BGMS on Glycaemic Control in Insulin-treated Diabetic Patients (NCT01588106) | GWT-TUD GmbH | 2012-06-01 |
| Comparison of Subject-driven Titration of Biphasic Insulin Aspart (BIAsp) 30 Twice Daily Versus Investigator-driven Titration of BIAsp 30 Twice Daily Both in Combination With Oral Antidiabetic Drugs in Subjects With Type 2 Diabetes (NCT01618214) | Novo Nordisk A/S | 2012-06-01 |
| Basal Bolus vs. Sliding Scale for Treatment of Diabetic Patients in Medical Wards (NCT01594060) | HaEmek Medical Center, Israel | 2012-06-01 |
| A Family-Based Diabetes Intervention for Hispanic Adults in an Emerging Community (NCT02114814) | Ohio State University | 2012-06-01 |
| Treatment Intensification With Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Inadequately Controlled on Sitagliptin and Metformin (NCT01519674) | Novo Nordisk A/S | 2012-06-01 |
| Comparing Patient-adjusted Versus Physician-adjusted Titration of BIAsp 30 Combined With Metformin in Type 2 Diabetes Patients (NCT01589653) | Novo Nordisk A/S | 2012-05-26 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetic a Single Day of Dosing With GSK1614235. (NCT01607385) | GlaxoSmithKline | 2012-05-18 |
| A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Saxagliptin (BMS-477118) in Combination With Metformin IR or Metformin XR in Pediatric Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone (NCT01434186) | AstraZeneca | 2012-05-01 |
| Linagliptin Among Filipino Patients With Type 2 Diabetes Mellitus (NCT01826370) | Boehringer Ingelheim | 2012-05-01 |
| A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0148-0000-0362 in Healthy Subjects (NCT01597713) | Novo Nordisk A/S | 2012-05-01 |
| The Effect of Liraglutide on the Treatment of Coronary Artery Disease and Type 2 Diabetes (NCT01595789) | Haugaard, Steen Bendix, M.D., DMSc | 2012-05-01 |
| The Effect of CBT- Based Weight Loss Program on Obesity (NCT01606904) | University of Oulu | 2012-05-01 |
| A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus (NCT01582451) | Eli Lilly and Company | 2012-05-01 |
| Testing the Effect of the InsuPad Device in Daily Life Conditions (NCT01594801) | Insuline Medical Ltd. | 2012-05-01 |
| French Observational Survey to Assess Hypoglycaemia in Insulin-treated Diabetic Patients (NCT01628341) | Novo Nordisk A/S | 2012-05-01 |
| The Medication Metronome Project - Study to Facilitate Follow-up Testing Resulting From Prescribed Medications to Improve Patient Safety and Care (NCT01586897) | Massachusetts General Hospital | 2012-05-01 |
| Large Scale Demonstrator, Webportal Diabetes (NCT01570140) | Henk Bilo, MD | 2012-05-01 |
| Stress Management Among Latinos With Type 2 Diabetes (NCT01578096) | Yale University | 2012-05-01 |
| Functional MRI Biomarkers of Cognitive Decrements in Diabetes (NCT01705210) | Maastricht University Medical Center | 2012-05-01 |
| Diabetes Visual Function Supplement Study (NCT01646047) | ZeaVision, LLC | 2012-05-01 |
| Pilot Assessment of the Effects of Bardoxolone Methyl on Renal Perfusion, Systemic Haemodynamics and Cardiac Function in Patients With Chronic Kidney Disease and Type 2 Diabetes (NCT01551446) | Biogen | 2012-04-30 |
| Pharmacokinetic and Pharmacodynamic Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes (NCT01549769) | Biogen | 2012-04-30 |
| Investigation of Optimal Dosing Conditions for a Long Acting GLP-1 Analogue in Healthy Male Subjects (NCT01572753) | Novo Nordisk A/S | 2012-04-12 |
| Efficacy and Safety of Liraglutide in Combination With Insulin Therapy Compared to Insulin Alone in Japanese Subjects With Type 2 Diabetes (NCT01572740) | Novo Nordisk A/S | 2012-04-05 |
| The Effects of LY2409021 on the Liver (NCT01588366) | Eli Lilly and Company | 2012-04-01 |
| A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin (NCT01570751) | Novo Nordisk A/S | 2012-04-01 |
| Renal Impairment Study of Empagliflozin (BI10773) in Japanese Patients With Type 2 Diabetes (NCT01581658) | Boehringer Ingelheim | 2012-04-01 |
| Antipsychotics and Risk of Hyperglycemic Emergencies (NCT02582736) | Canadian Network for Observational Drug Effect Studies, CNODES | 2012-04-01 |
| Exogenous Glucose Oxidation Breath Test (NCT01846767) | National University of Ireland, Galway, Ireland | 2012-04-01 |
| Does Early Weight Loss Following Laparoscopic Sleeve Gastrectomy Affect Long-term Outcomes (NCT04235829) | Shaare Zedek Medical Center | 2012-04-01 |
| Effect of Linagliptin in Comparison With Glimepiride as Add on to Metformin on Postprandial Beta Cell Function, Postprandial Metabolism and Oxidative Stress in Patients With Type 2 Diabetes Mellitus (NCT01547104) | Marcus Borchert | 2012-04-01 |
| Effects of Acute Exercise on Acetylcarnitine Concentration in Endurance Trained and Untrained Subjects (NCT01553968) | Maastricht University Medical Center | 2012-04-01 |
| Wine Consumption and Glycemic Control (NCT02518334) | University of Missouri-Columbia | 2012-03-01 |
| Individualized Lifestyle Intervention in Subjects With Prediabetes (NCT01947595) | University Hospital Tuebingen | 2012-03-01 |
| Korean Post-marketing Surveillance for Onglyza® (NCT01575483) | AstraZeneca | 2012-03-01 |
| Saxagliptin and Atherosclerosis (NCT01552018) | Oslo University Hospital | 2012-03-01 |
| A Study To Evaluate The Effects Of PF-05175157 In Healthy Volunteers (NCT01537497) | Pfizer | 2012-03-01 |
| A Community Pharmacy-based Program to Improve Management of Diabetes (NCT01525992) | Tehran University of Medical Sciences | 2012-03-01 |
| Life-Long Monitoring of Diabetes Mellitus in Veneto Region (NCT01569893) | Regione Veneto | 2012-03-01 |
| Diabetes Attitudes Wishes and Needs (NCT01507116) | Novo Nordisk A/S | 2012-03-01 |
| A Study to Compare the Effect of Giving Dulaglutide Using an Auto-injector Versus a Manual Syringe (NCT01524770) | Eli Lilly and Company | 2012-03-01 |
| A 3-fold Crossover Bioequivalence Study Between Glucobay ODT (Orally Disintegrating Tablet) 100 mg and Glucobay Standard Tablet 100 mg (NCT01554631) | Bayer | 2012-03-01 |
| Diagnosis and Physiopathology of Insulin Allergy (NCT01407640) | Assistance Publique - Hôpitaux de Paris | 2012-02-06 |
| Negative Postprandial Effect on Endothelium After a Not-healthy Meal in Type 2 Diabetes as Affected by Training (NCT01991769) | Norwegian University of Science and Technology | 2012-02-01 |
| Efficacy Study of Diabetes Group Visits (NCT01497301) | Oregon Health and Science University | 2012-02-01 |
| The Synergy to Control Emergency Department Hyperglycemia Program for Type 2 Diabetes (NCT02269098) | Medstar Health Research Institute | 2012-02-01 |
| Pharmacokinetic Profile of Two Formulations of PB1023 Following Single Subcutaneous Injection in Subjects With Type 2 Diabetes Mellitus (NCT01427257) | PhaseBio Pharmaceuticals Inc. | 2012-02-01 |
| Liraglutide Use in Prader-Willi Syndrome (NCT01542242) | Vancouver General Hospital | 2012-02-01 |
| Effects of Sitagliptin on Type 2 Diabetes Mellitus Patients on Treatment With Metformin and Insulin (NCT01341717) | Jothydev's Diabetes and Research Centre | 2012-02-01 |
| Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin (NCT01517373) | Pfizer | 2012-02-01 |
| Efficacy and Safety Comparison of Metformin/Glimepiride Combination Versus Each Compound Alone in New Diagnosed Type 2 Diabetes Patients (NCT01459809) | Sanofi | 2012-02-01 |
| Effect of Acute Fructose Load in Human (NCT03157960) | Karolinska University Hospital | 2012-02-01 |
| Evaluation of Food Effect on the Pharmacokinetics of Sustained Release Metformin in Healthy Indian Volunteers (NCT01561976) | GlaxoSmithKline | 2012-01-30 |
| A Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Insulin naïve Subjects With Type 2 Diabetes (NCT01513590) | Novo Nordisk A/S | 2012-01-16 |
| Safety and Efficacy of Liraglutide in Combination With an OAD in Subjects With Type 2 Diabetes Insufficiently Controlled on OAD Alone (NCT01512108) | Novo Nordisk A/S | 2012-01-10 |
| Linagliptin and Metformin Versus Linagliptin in Newly Diagnosed, Untreated Type 2 Diabetes (NCT01512979) | Boehringer Ingelheim | 2012-01-01 |
| Effects of Vitamin D on Beta Cell Function and Insulin Sensitivity in Pre-diabetes and Diabetes Mellitus Type 2 (NCT01497132) | Karolinska Institutet | 2012-01-01 |
| White Blood Cell Signaling and Defense Mechanisms in Patients With Diabetes Mellitus Type 2 and Periodontitis (NCT01848379) | Zentrum fuer Zahn-, Mund- und Kieferheilkunde | 2012-01-01 |
| GAPP 2 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Type 2 Diabetes Mellitus (NCT01950637) | Novo Nordisk A/S | 2012-01-01 |
| Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes (NCT01481116) | Takeda | 2012-01-01 |
| Roux-en-Y Gastric Bypass (RYGB) Versus Omega-Loop Gastric Bypass (OLGB) Safety and Efficacy Short-term Study (NCT02290418) | Nemocnice Břeclav, p.o. | 2012-01-01 |
| Effectiveness and Safety of Adding Compound Preparation of Pioglitazone and Metformin for Type 2 Diabetic Patients (NCT02099838) | Huazhong University of Science and Technology | 2012-01-01 |
| Exploratory CSII Trial on Erectile Dysfunction in T2DM Patients (NCT01468519) | Jothydev's Diabetes and Research Centre | 2012-01-01 |
| Diet and Exercise in Type 2 Diabetes - a Randomized Controlled Trial (NCT01513798) | Umeå University | 2012-01-01 |
| An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC) (NCT01511393) | Novo Nordisk A/S | 2012-01-01 |
| Microclinic Social Network Behavioral Health Trial in Jordan (NCT01818674) | Microclinic International | 2012-01-01 |
| Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated and Immediate Release Aspirin in Diabetic Patients (NCT01515657) | PLx Pharma | 2012-01-01 |
| A Study of the Effects of Canagliflozin on Plasma Volume in Patients With Type 2 Diabetes Mellitus (NCT01483781) | Janssen Research & Development, LLC | 2011-12-01 |
| Single Oral Dose of BeneFlax to Healthy Young and Older Adults (NCT01531569) | University of Saskatchewan | 2011-12-01 |
| A Comparison of Atorvastatin and Glimepiride Fixed Dose Combination and Atorvastatin and Glimepiride Loose Combination in the Treatment of Patients With Type 2 Diabetes Mellitus (NCT01495013) | GlaxoSmithKline | 2011-12-01 |
| A 2-week Trial Of PF-04991532 In Patients With Type 2 Diabetes (NCT01469065) | Pfizer | 2011-12-01 |
| Albiglutide Glucose Clamp Study in Subjects With Type 2 Diabetes (NCT01475734) | GlaxoSmithKline | 2011-12-01 |
| A Study in Participants With Type 2 Diabetes Mellitus (NCT01468987) | Eli Lilly and Company | 2011-12-01 |
| Pharmacokinetic, Safety/Tolerability Study of a Single SC Dose of PB1023 Injection in Subjects With Normal and Impaired Renal Function (NCT01478399) | PhaseBio Pharmaceuticals Inc. | 2011-12-01 |
| Efficacy and Safety of Vildagliptin as add-on Therapy to Metformin in Patients With Type 2 Diabetes (NCT01497522) | Novartis Pharmaceuticals | 2011-12-01 |
| Impact of a Diabetes Transitions Tool Kit on Post-Hospitalization Glycemic Control (NCT01495975) | Deborah Wexler, MD | 2011-12-01 |
| Resistance Training in Diabetic Elder Patients (NCT01638351) | National Taiwan University Hospital | 2011-12-01 |
| A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec in Subjects With Type 2 Diabetes (NCT01392573) | Novo Nordisk A/S | 2011-11-28 |
| Liraglutide or Insulin in Real Life Usage in Patients With Diabetes Mellitus Type 2 (NCT01484262) | Novo Nordisk A/S | 2011-11-14 |
| A Study to Determine the Safety, Tolerability, and Effects of GSK2374697 in Healthy Volunteers (NCT01545570) | GlaxoSmithKline | 2011-11-07 |
| Evaluating Safety of NovoPen® 3 and/or FlexPen® Devices in Routine Clinical Practice (NCT01454024) | Novo Nordisk A/S | 2011-11-01 |
| Linagliptin in Combination With Metformin in Treatment Naive Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic Control (NCT01438814) | Boehringer Ingelheim | 2011-11-01 |
| A Study in Patients With Type 2 Diabetes Mellitus (NCT01435616) | Eli Lilly and Company | 2011-11-01 |
| Study of RO6807952 in Patients With Diabetes Mellitus Type 2 (NCT01516476) | Hoffmann-La Roche | 2011-11-01 |
| Comparison of TAK-875 (Fasiglifam) With Placebo in Participants With Type 2 Diabetes (NCT01456195) | Takeda | 2011-11-01 |
| QR-Bromocriptine as an Adjunct to Insulin and Metformin in the Treatment of Type 2 Diabetes (NCT01474018) | University of Texas Southwestern Medical Center | 2011-11-01 |
| Comparative Bioavailability - Gender Effect - Single and Multiple Ascending Dose Safety and Pharmacokinetic Study of GFT505 (NCT01474161) | Genfit | 2011-11-01 |
| Comparing Efficacy and Safety of Insulin Detemir Plus Insulin Aspart and NPH Insulin Plus Human Soluble Insulin With or Without Metformin in Chinese Patients With Type 2 Diabetes (NCT01486966) | Novo Nordisk A/S | 2011-11-01 |
| Home Exercise to Enhance Mobility for Older Diabetics (NCT01308008) | VA Office of Research and Development | 2011-11-01 |
| Validating Non-invasive Measurements of Central Blood Pressure in Type 2 Diabetic Patients (NCT01538290) | University of Aarhus | 2011-11-01 |
| A First-in-Human Study of LY3009385 in Healthy Participants (NCT01477567) | Eli Lilly and Company | 2011-11-01 |
| (Cost-)Effectiveness of SLIMMER Diabetes Prevention Intervention (NCT02094911) | Wageningen University | 2011-10-01 |